• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » New FDA-backed initiative seeks to boost diversity in medtech

New FDA-backed initiative seeks to boost diversity in medtech

June 2, 2021 By Sean Whooley

MedTech Color LogoMedTech Color has launched a Collaborative Community on Diversity and Inclusion in Medical Device Product Development and Clinical Research.

The MedTech Color Collaborative Community aims to bring together public and private stakeholders and develop targeted strategies to up the awareness, understanding and participation of racial and ethnic minorities within the medtech industry, according to a news release.

“The FDA is committed to advancing diverse participation in trials to ensure that clinical studies better reflect the populations that will ultimately benefit from new and innovative health solutions,” director of the FDA’s Center for Devices & Radiological Health (CDRH) Dr. Jeff Shuren said in the release. “We are encouraged by MedTech Color’s active efforts to develop solutions to increase participant diversity and inclusion of minority health populations. We are also pleased to have FDA liaisons from CDRH and the Office of Minority Health and Health Equity participate in this collaborative community.”

The stated goals of the MedTech Color Collaborative Community include increasing clinical trial enrollment participation to represent diverse populations — and creating awareness of different disease states, prevalence rates in people of color and symptom recognition among minority populations.

Additionally, the collaborative community will recruit and retain minority physicians, researchers and other stakeholders in research and product development while identifying unmet needs and advancing research on health issues that are unique to minority populations.

The executive planning committee for the community includes MedTech Color board members Nada Hanafi (chief strategy officer, Experien Group) and Vernessa Pollard (partner and FDA practice leader, McDermott Will & Emery). Edwards VP of global clinical affairs Jaime Wheeler and Otsuka America Pharmaceutical deputy general counsel Kenita Barrow join Hanafi and Pollard on the committee.

“We created this community to bring together the passion, resources, and experience of organizations and individuals affected by the lack of diversity within the medtech space,” Hanafi said. “We’re looking forward to expanding our incredible group of dedicated professionals in all aspects of the industry – from clinicians, device and biotech companies, patient representatives, academic partners, legal professionals, nonprofits, government agencies, etc. and more.”

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA) Tagged With: diversity and inclusion, FDA, Medtech Color

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy